Eurofins MET Labs News and Activities

Eurofins MET Labs is owned by Eurofins.

Eurofins is one of the...

• CAC 40;
• CAC All-Trade;
• Fortune 500 Europe (#464);
• SBF 120;
• Stoxx 600;
• TOB Iconic 10,000.

Eurofins is a company listed under the stock ticker ERF (FR).

Eurofins has a direct presence in 12 countries.

Eurofins has 24 subsidiaries including Biomnis Ireland, Boston Heart Diagnostics and EAG.

They are in:

• Biotechnology80%
• Pharmaceuticals16%
• Other4%

Acquisition, funding and merger involving Eurofins.

• UL Solutions has announced the acquisition of Eurofins MET Labs  (posted on April 14 2026).

View the org chart displaying its 6 main executives

Most searched biographies at Eurofins MET Labs

• Nimer Al-Hafi, President
• Chris Wyman, Vice President
• Cynthia Chadwell, Senior Quality Management Systems Manager

Popular executive movements at Eurofins

• Charles Billard has joined the company as Deputy Chief Financial Officer  (posted on April 13 2026).

Create your alert
to follow the executive moves at Eurofins MET Labs.

Eurofins has 2,403 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and BioNTech (Germany).

Popular M&A news in Biotechnology

• GNI has announced the acquisition of Ayumi Pharmaceutical  (posted on June 12 2026).
• Humacyte has just announced a $50 Million fundraising (posted on June 12 2026).
• Beren Therapeutics has just announced a $300 Million fundraising (posted on June 12 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Eurofins MET Labs

Social media about Eurofins MET Labs

• Eurofins MET Labs on Wikipedia, Google News & Yahoo Finance
• Eurofins MET Labs on LinkedIn, X (Twitter) & YouTube